Dr. Benjamin Charles Kalayjian, MD
- Part D claims, 2024
- 506
- Industry payments
- $736
- Affiliated sites
- 1
- Medical group
- 1
- State license
- 1
- Practice address
- 1631 Elysian Fields Avenue, New Orleans, LA 70117
- Practice phone
- Call (504) 821-2601
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
CrescentCare Elysian Fields
FQHC - Main Site · New Orleans, Louisiana
Find Dr. Kalayjian's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Benjamin Charles Kalayjian is an internist in New Orleans, Louisiana
Dr. Kalayjian practices at CrescentCare Elysian Fields in New Orleans, Louisiana.
Dr. Kalayjian's NPI, 1831584853, was assigned on April 6, 2015. Dr. Kalayjian graduated from Tulane University School of Medicine in 2015. Dr. Kalayjian holds Louisiana license MD310368.
- NPI
- 1831584853NPI Registry (opens in a new tab)
- NPI enumeration date
- April 6, 2015
- NPI status
- Active
- Practice phone
- (504) 821-2601
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 37
- Medical school graduation
- 2015
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Benjamin Charles Kalayjian practices at CrescentCare Elysian Fields in New Orleans, Louisiana
Dr. Kalayjian's primary practice is CrescentCare Elysian Fields, at 1631 Elysian Fields Avenue, New Orleans, LA 70117 in Orleans Parish. The practice phone is (504) 821-2601.
- CrescentCare Elysian Fields1631 Elysian Fields Avenue, New Orleans, LA 70117 · Orleans ParishPhone(504) 821-2601
Source: Dmand AI Affiliation Data
Dr. Benjamin Charles Kalayjian is affiliated with 1 site of care and 1 medical group
Dr. Kalayjian's primary practice is CrescentCare Elysian Fields in New Orleans, Louisiana. The medical group on file is CrescentCare. Dr. Kalayjian's employer is on file too: a community health center (fqhc).
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Benjamin Charles Kalayjian's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalayjian practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| CrescentCare Elysian Fields | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Benjamin Charles Kalayjian is one of 1,571 internists in Louisiana
Internal medicine is Dr. Kalayjian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kalayjian is licensed in Louisiana.
Specialties and state licenses
- Internal medicine, LouisianaPrimary
Internists near Dr. Kalayjian
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Benjamin Charles Kalayjian's patients have a median age of 36
Across all payers, Dmand AI patient panel data puts Dr. Kalayjian's median patient age at 36, with 39% women.
Dr. Kalayjian's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 36
Patient panel by sex, all payers
- Women39%
- Men60%
Source: Dmand AI Patient Panel Data
Dr. Benjamin Charles Kalayjian wrote 506 Medicare Part D claims in 2024
In 2024, Dr. Kalayjian wrote 506 Medicare Part D claims for 49 patients. 75% of them were for generic drugs. CMS names the drug for 342 of them, across 14 drugs with 11 or more claims each, at $323,345 in total drug cost. In 2023, CMS named 844 claims across 30 drugs.
Dr. Kalayjian's Part D claims by kind of drug, 2024
- Generic382 claims75%
- Brand-name and other124 claims25%
Dr. Kalayjian's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kalayjian's Part D claims, 2024
- Antipsychotics, patients 65 and over4%18 of 506 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8442024: 34259%
Drugs named by CMS: 14 in 2024, 30 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Benjamin Charles Kalayjian received $736 in industry payments from 2022 to 2025
CMS Open Payments shows 38 general payments to Dr. Kalayjian from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $441.
General payments to Dr. Kalayjian by program year, 2022 to 2025
Companies that paid Dr. Kalayjian the most, 2022 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Benjamin Charles Kalayjian graduated from Tulane University School of Medicine
Dr. Kalayjian graduated from Tulane University School of Medicine in 2015.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Benjamin Charles Kalayjian's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Benjamin Charles Kalayjian
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Benjamin Charles Kalayjian's NPI number?
Dr. Benjamin Charles Kalayjian's NPI number is 1831584853. It was assigned on April 6, 2015, and it is active in the NPI Registry.
What kind of doctor is Dr. Benjamin Charles Kalayjian?
Dr. Benjamin Charles Kalayjian is an internist in New Orleans, Louisiana. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Benjamin Charles Kalayjian practice?
Dr. Kalayjian practices at 1631 Elysian Fields Avenue, New Orleans, LA 70117. Dr. Kalayjian's primary practice is CrescentCare Elysian Fields in New Orleans, Louisiana.
What is Dr. Benjamin Charles Kalayjian's office phone number?
The practice phone on file for Dr. Kalayjian is (504) 821-2601.
What is Dr. Benjamin Charles Kalayjian's medical license number?
Dr. Kalayjian holds Louisiana license MD310368.
What medical group is Dr. Benjamin Charles Kalayjian part of?
Dr. Kalayjian is linked to CrescentCare.
Where did Dr. Benjamin Charles Kalayjian go to medical school?
Dr. Kalayjian graduated from Tulane University School of Medicine in 2015.
What drugs does Dr. Benjamin Charles Kalayjian prescribe most?
In 2024 Medicare Part D data, Dr. Kalayjian's most prescribed drugs by claims were Buprenorphine-Naloxone, Albuterol Sulfate Hfa and Amlodipine Besylate.
Has Dr. Benjamin Charles Kalayjian received payments from drug or device companies?
CMS Open Payments shows $736 in general payments to Dr. Kalayjian from 4 companies from 2022 to 2025. The largest total came from Gilead Sciences, Inc.
How long has Dr. Benjamin Charles Kalayjian been practicing?
Dr. Kalayjian graduated from medical school in 2015, 11 years ago.
Selling to internal medicine practices?
See internists in Louisiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card